Nutrafol vs Minoxidil: Which Actually Regrows Hair?

Short answer

Nutrafol and minoxidil are often compared as if they sit on the same shelf. They do not.

Minoxidil is a hair-growth medication. FDA-approved for pattern hair loss. Decades of clinical use. Works directly at the follicle level to support the growth phase of hair. Nutrafol is a premium nutraceutical supplement. Its best case is not replacing minoxidil. It may support hair growth when thinning is connected to stress physiology, inflammation, nutrition gaps, hormones, or shedding after a major body stressor.

If you want the highest probability of measurable regrowth in androgenetic alopecia, minoxidil wins. If you are dealing with temporary shedding, poor intake after weight loss, stress-related thinning, or you want a supplement adjunct rather than a drug-like treatment, Nutrafol becomes a more reasonable conversation.

Study snapshots: the trials behind this guide

Study Snapshot: Feldman et al. 2023

The Bayesian network meta-analysis[1] behind the “minoxidil beats Nutrafol” comparison. Here is what was actually pooled, in whom, and what was estimated.

What this study shows

• In a pooled Bayesian model, topical minoxidil 2% produced a higher terminal-hair-count estimate than Nutrafol at 24 weeks in women with androgenetic alopecia.
• Nutrafol was not zero — it showed a positive terminal-hair signal in the same model.
• The 12.13 vs 7.32 comparison is an estimated network result, not a direct trial measurement in the same room.

What this study does not show

• It does not prove Nutrafol is ineffective. It shows minoxidil has a stronger estimated terminal-hair signal in this specific population.
• It does not cover telogen effluvium, postpartum shedding, or stress-related hair loss — the contexts where Nutrafol’s rationale is more coherent.
• It does not include long-term data beyond 24 weeks.
• It relies on sponsor-linked Nutrafol trials as input data, so the Nutrafol estimate inherits that limitation.

Study Snapshot: Ablon and Kogan 2018

The primary Nutrafol randomized trial — what was actually tested, in whom, and what was reported.

What this study shows

• A manufacturer-sponsored RCT reported that Nutrafol improved terminal and total hair counts in women with self-perceived thinning over 6 months.
• The design was randomized, double-blind, and placebo-controlled — the methodological baseline for a credible supplement trial.

What this study does not show

• It does not prove Nutrafol matches minoxidil — it tested Nutrafol against placebo, not against minoxidil.
• It does not enroll men, so the result does not transfer to male pattern hair loss.
• It does not separate which ingredient in the multi-ingredient formula drove the effect.
• Sponsor linkage means the trial team has a commercial interest in a positive result.

The verdict

Minoxidil is the stronger regrowth tool. In a Bayesian network meta-analysis of randomized placebo-controlled trials in androgenetic alopecia (Feldman et al., Frontiers in Medicine, 2023)[1], women using topical minoxidil 2% had an estimated 12.13 additional terminal hairs per cm² at 24 weeks. Nutrafol had 7.32 terminal hairs per cm². Roughly a 66% higher measured terminal-hair gain for minoxidil in that model.

That does not make Nutrafol useless. It means Nutrafol should be framed honestly — not as the cheaper, natural version of minoxidil. It is a supplement with some clinical evidence, a high monthly cost, and a role that becomes more persuasive when the hair problem is connected to stress, nutrition, shedding, or a desire to add support around a primary treatment.

Choose minoxidil first if:

• You have diagnosed or likely androgenetic alopecia.
• Thinning is gradual, patterned, family-history driven.
• You want the cheaper and more proven regrowth option.
• You can commit to consistent use.

Consider Nutrafol if:

• Your shedding followed stress, illness, postpartum changes, rapid weight loss, or GLP-1-related under-eating.
• You want an oral supplement approach and understand the limits.
• You are looking for an adjunct, not a replacement.
• You can afford a 3–6 month trial without expecting drug-like results.

Do not confuse the two. One is a medication for follicle stimulation. The other is a multi-ingredient supplement built around a broader “hair wellness” theory.

Nutrafol vs minoxidil comparison table

The evidence: why minoxidil still wins the head-to-head

The best comparative number in this conversation comes from a systematic review and continuous Bayesian network meta-analysis published in Frontiers in Medicine (Feldman et al., 2023)[1]. It pooled randomized placebo-controlled trials in androgenetic alopecia and compared terminal hair regrowth at 12 and 24 weeks.

Terminal hair matters because it is the thicker, cosmetically meaningful hair people actually notice. A product can improve “hair wellness” language, shedding perception, or vellus hair counts and still not create the kind of visible density a reader is hoping for. Terminal hairs are closer to the outcome people mean when they say, “Is this actually regrowing hair?”

In women at 24 weeks, the analysis estimated:

• Minoxidil 2%: 12.13 additional terminal hairs/cm².
• Minoxidil 5%: 10.82 additional terminal hairs/cm².
• Nutrafol: 7.32 additional terminal hairs/cm².

Same model. Same endpoint. Same timeframe. Minoxidil 2% delivered 66% more terminal hair than Nutrafol.

The numbers confirm Nutrafol was not empty placebo theater in this evidence set — and show why minoxidil remains the more serious regrowth tool.

The difference is not just mathematical. It changes the buying decision. For clear female pattern hair loss where the goal is the highest-probability first-line topical option, it is hard to argue Nutrafol should come before minoxidil. For someone already using minoxidil, unable to tolerate it, or carrying a shedding story that sounds more nutritional or stress-related than purely androgenetic, Nutrafol may have a more coherent role.

What minoxidil actually does

Minoxidil is sometimes described as a vasodilator — true historically, incomplete as a hair-loss explanation. Its hair effect appears to involve follicle biology, growth-cycle signaling, and prolongation of the anagen phase, the active growth phase of hair.

Minoxidil pushes follicles toward growth. That is why it has remained the default over-the-counter treatment for pattern hair loss for so long.

It is also why stopping matters. Minoxidil does not permanently cure the underlying pattern. If the follicle miniaturization pressure is still there and minoxidil is removed, the gained hair can gradually be lost. For some readers, that lifetime-commitment part is the dealbreaker. For others, it is acceptable because generic topical minoxidil is cheap and the evidence is stronger than most supplement alternatives.

Choosing a minoxidil product

Start with the boring questions. Foam or solution? Once daily or twice daily? Can you tolerate it on the scalp? Will it ruin your routine enough that you stop using it after three weeks?

Foam is often preferred by people who get irritation from solution formulas, partly because some solutions contain propylene glycol. Solution can be cheaper and easier to apply to certain scalp areas. The right product is the one a person can use consistently without turning the scalp into a daily negotiation.

For women, topical 5% foam once daily and 2% solution twice daily are both commonly discussed; clinicians may individualize based on diagnosis, irritation, pregnancy plans, and unwanted facial hair risk. Oral minoxidil is a separate conversation — prescription, off-label for hair loss in many contexts, systemic side-effect considerations.

What Nutrafol actually does

Nutrafol is not a single-ingredient hair-growth pill. It is a multi-ingredient formula built on a simple idea: thinning hair rarely has just one cause. Depending on the formula, ingredients may include saw palmetto, ashwagandha, curcumin, tocotrienols, marine collagen, vitamins, minerals, and other botanicals.

That makes Nutrafol harder to evaluate than minoxidil. With minoxidil, the question is whether a known medication helps a known hair-loss pattern. With Nutrafol, the question is whether a multi-target supplement meaningfully improves hair outcomes in the kind of person enrolled in its studies — and whether that person looks like you.

The Nutrafol evidence base is better than the average hair supplement. Randomized placebo-controlled trials in women with self-perceived thinning (Ablon and Kogan, Journal of Drugs in Dermatology, 2018)[2] reported significant improvements in terminal and total hair counts over 6 months. A menopausal-women trial (Ablon, 2021)[3] also reported improvements in terminal and total hair counts and reduced shedding versus placebo.

The caveat matters: these are smaller nutraceutical trials, and many are sponsor-linked. That does not automatically invalidate them. It means a serious reader should not treat them like the same evidence category as decades of broad minoxidil use.

Thinking about Nutrafol

Don’t buy Nutrafol because the bottle says “clinically tested.” That phrase is too easy to overuse. Consider it only when the situation makes sense: shedding after stress, low intake, postpartum or hormonal transition under clinician guidance, weight-loss-related nutrition disruption, or a preference for a supplement adjunct after understanding that minoxidil has stronger regrowth evidence.

Cost has to be part of the evidence discussion. A $90/month supplement needs a clearer reason than “hair health.” The honest test is whether you can name the trigger you are trying to support, tolerate the formula, avoid ingredient conflicts, and commit long enough to judge the outcome.

Nutrafol also asks for adherence. Four capsules a day is not nothing — especially for someone already dealing with nausea, GLP-1 appetite changes, or a long medication list.

When minoxidil makes more sense

Minoxidil usually makes more sense when the hair loss looks like androgenetic alopecia: gradual thinning at the crown, widening part, temple recession, miniaturized hairs, or a family pattern that is hard to ignore.

It also makes sense when the reader wants the most proven non-prescription regrowth tool and is willing to accept the trade-offs. Those trade-offs are real: possible irritation, a temporary shedding phase, unwanted facial hair if the product transfers, daily application, and loss of gains after stopping.

If the question is “which one is more likely to regrow measurable hair in pattern hair loss?” — minoxidil is the cleaner answer.

The minoxidil drawback readers should know

The most common failure point is routine fatigue. People buy minoxidil during a panic week, apply it carefully for ten days, then stop because the hair does not look different yet. Hair biology is slow. A fair trial takes months, not days, and some early shedding can happen before visible improvement.

That is why minoxidil is best for someone who can treat it like brushing teeth: boring, consistent, and not emotionally re-decided every morning.

When Nutrafol makes more sense

Nutrafol makes more sense when the hair-loss story is not purely a follicle-stimulation problem.

The clearest example is telogen effluvium: sudden shedding after a stressor. Illness, surgery, postpartum changes, emotional stress, crash dieting, rapid weight loss, or under-eating after GLP-1 medication. In that situation, the reader does not describe slow pattern thinning. They describe handfuls of hair in the shower, a ponytail that feels smaller, a frightening sense that something changed quickly.

Nutrafol is not a guaranteed answer in that scenario. But the rationale becomes more coherent because the problem may involve stress signaling, inadequate intake, micronutrient issues, inflammation, or hormonal transition — not only androgen-driven follicle miniaturization.

If a GLP-1 user is losing hair after rapid weight loss, look at protein intake, iron/ferritin status, thyroid context, total calories, vitamin D, zinc, menstrual history, and the pace of weight loss before making Nutrafol the centerpiece. A supplement can be part of the plan. It should not distract from the basics.

Hair shedding after rapid weight loss is often a nutrition and stress signal, not proof that you need an expensive hair stack. If appetite has collapsed after starting a GLP-1 medication, protein intake and the pace of weight loss may matter more than a hair supplement; that framework is covered in our GLP-1 companion guide.

Can you use Nutrafol and minoxidil together?

Yes — and this is often the more realistic dermatologist-style answer. They are not doing the same job.

Minoxidil is the follicle-directed growth tool. Nutrafol is the broader supplement support tool. For pattern hair loss plus a plausible stress or nutrition layer, using both may be more coherent than forcing a false choice.

“Can use together” does not mean “everyone should buy both.” The combined approach is expensive and asks for more adherence. It also makes it harder to know what helped. If a reader starts minoxidil, Nutrafol, collagen, a multivitamin, scalp serum, rosemary oil, and a new shampoo in the same month, the only thing they have proven is that panic is expensive.

A better approach is staged:

1. Get the hair-loss pattern assessed if possible.
2. Start the highest-probability intervention for that pattern.
3. Fix obvious nutrition and health gaps.
4. Add a supplement only if the reason remains clear.
5. Take photos monthly, not daily.

Buying and safety

What to check before buying either one

For the full label-reading framework, see our 90-second supplement label checklist. The criteria below are the article-specific application.

Hair loss is emotionally urgent, but the biology is slow. That mismatch is what makes the category so profitable and so easy to abuse.

Ask yourself: is this slow, steady thinning, or did your ponytail suddenly shrink last month? One points more toward a follicle problem. The other points more toward a trigger.

Then look backward. Illness, childbirth, surgery, rapid weight loss, GLP-1 medication, calorie restriction, emotional stress, and new medications can all show up in the hair weeks or months later. The scalp often reports the stress after the calendar has moved on.

The boring checks still matter: protein intake, ferritin or iron status, thyroid markers, vitamin D, zinc, and medication history. Less exciting than a hair-growth stack. More likely to explain why the hair changed in the first place.

Finally, ask whether the claim matches the evidence. “Supports thicker-looking hair” is not the same as “treats androgenetic alopecia,” and a product you cannot use consistently for months is not really part of the plan.

Safety and who should be cautious

Minoxidil can cause scalp irritation, itching, flaking, unwanted facial hair, and early shedding. Use carefully around pregnancy and breastfeeding decisions. Oral minoxidil should be discussed with a clinician — it can affect blood pressure, heart rate, fluid retention, and other systemic issues.

Nutrafol is a supplement. That does not mean it is automatically casual. Multi-ingredient formulas can matter for people who are pregnant or breastfeeding, trying to conceive, using hormone-related medications, taking blood thinners, managing thyroid disease, using sedatives or psychiatric medications, or dealing with autoimmune conditions. Saw palmetto, ashwagandha, iodine-containing ingredients, botanicals, and marine-derived ingredients are not invisible just because they are sold in a wellness bottle.

If hair loss is sudden, patchy, painful, associated with scalp inflammation, or accompanied by fatigue, menstrual changes, rapid weight changes, or other systemic symptoms — the right next step is medical evaluation, not a bigger supplement order.

This article is educational. It does not replace dermatology care or medical advice.

Nutrafol vs minoxidil is the wrong question if it means “which one is the better version of the same thing?” They are not versions of the same thing.

Minoxidil is the stronger regrowth treatment for pattern hair loss. Cheaper. More established. More directly tied to follicle stimulation. Nutrafol is the more plausible supplement adjunct when the hair-loss story involves stress, nutrition, shedding, hormonal transition, or a reader who wants broader support and accepts a higher monthly cost.

Choose minoxidil when the problem is follicle miniaturization. Consider Nutrafol when the problem looks more like a trigger, a deficiency, or an adjunctive support case.

If you cannot tell which story you are in, do not let the checkout page decide for you.

FAQ

Some links may earn us a commission at no extra cost to you. Our recommendations are based on published criteria, evidence quality, label transparency, and practical use cases, not paid placement.

How this article was researched

Evidence scan: PubMed and Cochrane, June 2026. Search terms included “Nutrafol hair growth RCT,” “nutraceutical supplement hair loss women,” “minoxidil female pattern hair loss,” “Bayesian network meta-analysis androgenetic alopecia,” “terminal hair count per cm²,” and “Ablon hair supplement trial.”

Priority given to: head-to-head comparative trials, continuous Bayesian network meta-analyses reporting terminal hair counts, and placebo-controlled trials in women with self-perceived thinning. The Feldman et al. Bayesian network meta-analysis[1] was read for its specific terminal-hair-per-cm² estimates rather than summarized as “minoxidil works.”

Sponsor-linked trials flagged: Ablon and Kogan 2018[2] and Ablon 2021[3] were sponsored by the manufacturer. That does not invalidate the data, but it places them in a different evidence category than decades of broad minoxidil use. The 12.13 vs 7.32 terminal-hair numbers are presented with that context, not as a clean head-to-head verdict.

Research date: June 2026. Updates planned when new comparative trials, Bayesian network meta-analyses, or sponsor-independent nutraceutical trials publish.